Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
McKinsey
Colorcon
AstraZeneca
McKesson

Last Updated: April 3, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Idebenone


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Idebenone?

Idebenone is an investigational drug.

There have been 27 clinical trials for Idebenone. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Cerebellar Ataxia, Ataxia, and Friedreich Ataxia. The leading clinical trial sponsors are Santhera Pharmaceuticals, National Institute of Neurological Disorders and Stroke (NINDS), and Second Affiliated Hospital, School of Medicine, Zhejiang University.

There are six hundred and fifty-nine US patents protecting this investigational drug and five international patents.

Recent Clinical Trials for Idebenone
TitleSponsorPhase
A Study of Efficacy and Safety of Idebenone vs. Placebo in Prodromal Parkinson DiseaseSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2/Phase 3
Idebenone for the Preventive Treatment of MigraineSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 3
Idebenone Treatment of Early Parkinson's DiseasesymptomsQilu Pharmaceutical Co., Ltd.Phase 4

See all Idebenone clinical trials

Clinical Trial Summary for Idebenone

Top disease conditions for Idebenone
Top clinical trial sponsors for Idebenone

See all Idebenone clinical trials

US Patents for Idebenone

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Idebenone   Start Trial Cellulose micropowder ASAHI KASEI KABUSHIKI KAISHA (Tokyo, JP)   Start Trial
Idebenone   Start Trial Composition for hot-melt extrusion and method for producing hot-melt extrusion product using same Shin-Etsu Chemical Co., Ltd. (Tokyo, JP)   Start Trial
Idebenone   Start Trial Deuterated idebenone Concert Pharmaceuticals, Inc. (Lexington, MA)   Start Trial
Idebenone   Start Trial Compositions and methods for improving human health and nutrition BiOWiSH Technologies, Inc. (Cincinnati, OH)   Start Trial
Idebenone   Start Trial Compounds which inhibit neuronal exocytosis LUBRIZOL ADVANCED MATERIALS, INC (Cleveland, OH)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Idebenone

Drugname Country Document Number Estimated Expiration Related US Patent
Idebenone European Patent Office 3181616 2034-08-12   Start Trial
Idebenone Japan 6216074 2034-08-12   Start Trial
Idebenone Japan WO2016024493 2034-08-12   Start Trial
Idebenone Taiwan 201613646 2034-08-12   Start Trial
Idebenone Taiwan I572360 2034-08-12   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Express Scripts
Johnson and Johnson
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.